Daryl Dee Shank

Title: Daryl Dee Shank: Innovator in Mycobacterial DNA Detection

Introduction

Daryl Dee Shank is a notable inventor based in Bel Air, MD (US). He has made significant contributions to the field of molecular biology, particularly in the detection of mycobacterial DNA. His innovative work has implications for the identification of various species of mycobacteria, which are crucial in medical diagnostics.

Latest Patents

Daryl Dee Shank holds a patent for "Amplification and detection of mycobacterial DNA K nucleic acids." This patent outlines methods for the identification or detection of a species of an organism or a group of related species through species non-specific amplification of a target sequence. The patent also details the use of a target sequence that can be amplified in multiple species of mycobacteria using a single pair of amplification primers. Additionally, it includes species- and group-specific detector probes for hybridization to the assay region of the amplified target. The use of blocking oligonucleotides is also described, allowing for discrimination among species with similar amplified target sequences that may cross-hybridize to an assay probe.

Career Highlights

Daryl Dee Shank is associated with Becton Dickinson and Company Limited, where he applies his expertise in molecular diagnostics. His work at this esteemed company has allowed him to contribute to advancements in medical technology and diagnostics.

Collaborations

Throughout his career, Daryl has collaborated with notable colleagues, including Colleen M. Nycz and James G. Nadeau. These collaborations have further enhanced the impact of his work in the field.

Conclusion

Daryl Dee Shank's contributions to the detection of mycobacterial DNA represent a significant advancement in molecular biology. His innovative patent and work at Becton Dickinson highlight his role as a key figure in the field of diagnostics.